RWJ-50271 | Interleukin Related interleukin-related.com

Product Name :
RWJ-50271

Search keywords :
RWJ 50271

drugId :
null

Target Vo:
Integrin alpha-L/beta-2 (LFA-1)

Target Vo Short Name :
ITGAL&ITGB2

Moa_Name:
Integrin alpha-L/beta-2 (LFA-1) antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Arthritis, Rheumatoid

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anti-Mouse IL-1b Antibody (B122) Biological Activity
Isatuximab (anti-CD38) supplier
APG5L Antibody: APG5L Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 32 kDa, targeting to APG5L. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts